Rabies Prevention

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Rabies Prevention trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07327307

Real World Evidence Study of SYN023 in Children Exposed to Rabies

This observational study is an open-label, prospective, multi-center design. The goal is to evaluate the long-term clinical survival outcomes at 3 months and 1…

China232 participantsStarted 2025-08-02Updated 2026-04-23

All recent trials (51 shown)

CompletedPhase 2

NCT03961555

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

This is a Phase 2b, double blinded, randomized study of SYN023 compared to HyperRab® (a licensed Rabies immune globulin from human sources, HRIG) for the preven…

United States, Philippines448 participantsStarted 2019-09-03Updated 2026-06-29

Treatment: SYN023, HRIG (HyperRab)

CompletedNot Applicable

NCT01044199

Study of Intradermal Administration of PCEC Rabies Vaccine

The purpose of this study is to determine immunogenicity and safety of intradermal administration of the PCEC rabies vaccine in adults.

United States130 participantsStarted 2009-02Updated 2026-06-24

Rabies Prevention

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Real World Evidence Study of SYN023 in Children Exposed to Rabies

All recent trials (51 shown)

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Study of Intradermal Administration of PCEC Rabies Vaccine

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Real World Evidence Study of SYN023 in Children Exposed to Rabies

All recent trials (51 shown)

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Study of Intradermal Administration of PCEC Rabies Vaccine

Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang

A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and…

A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)

Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.

Safety and Immunogenicity of ID vs IM Rabies Vaccine

SYN023 With Rabies Vaccine in Healthy Pediatric Subjects

Survey of Human Rabies Immune Globulin Safety in Children

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophyl…

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophyl…

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen

Study to Evaluate GR1801's Efficacy and Safety

A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried

A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vacc…

Prevention of Rabies With Four Doses of Rabies Vaccine

Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally

Vaccine Prevention of Rabies Adopts 4-shot Immunization Method